National News
Sending this article:
Merck Defends Vioxx as 'One of Most-Studied' Drugs at Latest Trial
National News • March 8, 2006
An attorney for Merck & Co. insisted at the start of another Vioxx trial that the company adequately investigated the drug's safety and asserted it was heart disease and other ailments, not Vioxx, ...
The information entered on this page will not be used to send unsolicited email, and will not be sold to a 3rd party.
